CytoDyn secures $12M as dispute with CRO reaches settlement: Positive impact on antibody drug trials
Amid a period of clinical holds and legal tangles, the US antibody specialist CytoDyn has reached a settlement to resolve legal disputes with its former contract research organization (CRO) Amarex Clinical Research.